ATE119390T1 - Arzneimittel. - Google Patents

Arzneimittel.

Info

Publication number: ATE119390T1
Authority: AT; Austria
Prior art keywords: sodium; carbonate; plus; malic; granules
Prior art date: 1990-04-07

Application number

AT91907023T

Other languages

English (en)

Inventor

David Roy Merrifield

Paul Laurence Carter

David George Smithklin Doughty

Road Bottom

Original Assignee

Beecham Group Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-04-07

Filing date

1991-04-02

Publication date

1995-03-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10674100&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE119390(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1991-04-02 Application filed by Beecham Group Plc filed Critical Beecham Group Plc

1995-03-15 Application granted granted Critical

1995-03-15 Publication of ATE119390T1 publication Critical patent/ATE119390T1/de

Links

239000003814 drug Substances 0.000 title 1
229940079593 drug Drugs 0.000 title 1
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 3
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 abstract 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 2
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 abstract 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 abstract 1
LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 abstract 1
229960003022 amoxicillin Drugs 0.000 abstract 1
RRPFCKLVOUENJB-UHFFFAOYSA-L disodium;2-aminoacetic acid;carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O.NCC(O)=O RRPFCKLVOUENJB-UHFFFAOYSA-L 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000008187 granular material Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
229910052700 potassium Inorganic materials 0.000 abstract 1
239000011591 potassium Substances 0.000 abstract 1
239000000843 powder Substances 0.000 abstract 1
229910000030 sodium bicarbonate Inorganic materials 0.000 abstract 1
235000017557 sodium bicarbonate Nutrition 0.000 abstract 1
229910000029 sodium carbonate Inorganic materials 0.000 abstract 1
159000000000 sodium salts Chemical class 0.000 abstract 1
239000003826 tablet Substances 0.000 abstract 1
239000011975 tartaric acid Substances 0.000 abstract 1
235000002906 tartaric acid Nutrition 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Detergent Compositions (AREA)

AT91907023T 1990-04-07 1991-04-02 Arzneimittel. ATE119390T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB909007945A GB9007945D0 (en)	1990-04-07	1990-04-07	Pharmaceutical formulation

Publications (1)

Publication Number	Publication Date
ATE119390T1 true ATE119390T1 (de)	1995-03-15

Family

ID=10674100

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91907023T ATE119390T1 (de)	1990-04-07	1991-04-02	Arzneimittel.

Country Status (12)

Country	Link
EP (1)	EP0524211B2 (de)
JP (1)	JP3234946B2 (de)
AT (1)	ATE119390T1 (de)
AU (1)	AU7558691A (de)
CA (1)	CA2079904A1 (de)
DE (1)	DE69108022T3 (de)
GB (1)	GB9007945D0 (de)
IE (1)	IE911148A1 (de)
NZ (1)	NZ237710A (de)
PT (1)	PT97264A (de)
WO (1)	WO1991015197A1 (de)
ZA (1)	ZA912538B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9114950D0 (en) *	1991-07-11	1991-08-28	Smithkline Beecham Plc	Pharmaceutical formulation
FR2714064B1 (fr) *	1993-12-16	1996-03-08	Edmond Creppy	Aspartame pour son application en tant que substance thérapeutiquement active.
GB9416599D0 (en) *	1994-08-17	1994-10-12	Smithkline Beecham Plc	Pharmaceutical formulation
DZ2028A1 (fr)	1995-05-03	2002-10-23	Smithkline Beecham Plc	Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
AR004510A1 (es) *	1995-09-07	1998-12-16	Smithkline Beecham Plc	Composiciones que comprenden amoxicilina y clavulanato, procedimientos para su preparacion y el uso de las composiciones para la fabricacion de unmedicamento
GB9616728D0 (en) *	1996-08-09	1996-09-25	Conte Rolland R	Process, product and package
GB9617658D0 (en) *	1996-08-23	1996-10-02	Conte Rolland R	Process
US6878386B1 (en)	1999-04-13	2005-04-12	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en)	1999-04-13	2001-09-25	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection comprising administering amoxycillin
AP1806A (en) *	1999-04-13	2007-12-14	Beecham Pharmaceuticals Pte Ltd	The use of a high dosage regimen of amoxycillin and potassium chavulate for the treatment of bacterial infections.
US7250176B1 (en)	1999-04-13	2007-07-31	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection
SI20411A (sl) *	1999-12-22	2001-06-30	LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d.	Vodotopni praški za peroralno raztopino in njihova uporaba
FR2812199A1 (fr) *	2000-07-31	2002-02-01	Maximun Frederic Yanze	Nouvelles compositions pharmaceutiques effervescentes contenant la chloroquine
US6756057B2 (en)	2000-10-12	2004-06-29	Beecham Pharmaceuticals (Pte) Limited	Amoxicillin and potassium clavulanate dosage form
WO2002030392A2 (en)	2000-10-12	2002-04-18	Beecham Pharmaceuticals (Pte) Limited	Formulation containing amoxicillin
EP1541129A1 (de) *	2003-12-12	2005-06-15	Cimex AG	Amoxycillin und Clavulanat enthaltende pharmazeutische Brauseformulierung
WO2014174405A1 (en) *	2013-04-22	2014-10-30	Webb Johannes Arnoldus Vosloo	Pharmaceutical preparation
CN116115571A (zh) *	2023-04-04	2023-05-16	内蒙古联邦动保药品有限公司	高浓度阿莫西林可溶性粉剂及其制备方法
CN118267361B (zh) *	2024-05-31	2024-08-23	潍坊格润药业有限公司	一种兽用复方阿莫西林可溶性粉

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT307616B (de) *	1969-05-02	1973-05-25	Biochemie Gmbh	Verfahren zur Herstellung einer Brausezubereitung
EP0080862B1 (de) *	1981-12-02	1985-09-25	Beecham Group Plc	Pharmazeutische Zubereitung die Beta-Lactam Antibiotika enthält
DE3440288C2 (de) *	1984-11-05	1987-03-12	Gergely, Gerhard, Dr.-Ing., Wien	Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
LU85943A1 (fr) *	1985-06-12	1987-01-13	Galephar	Comprimes pharmaceutiques permettant l'administration aisee de pellets, leur preparation et leur utilisation
DE3887179T2 (de) *	1987-03-02	1994-06-16	Brocades Pharma Bv	Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.

1990
- 1990-04-07 GB GB909007945A patent/GB9007945D0/en active Pending
1991
- 1991-04-02 JP JP50651391A patent/JP3234946B2/ja not_active Expired - Fee Related
- 1991-04-02 AT AT91907023T patent/ATE119390T1/de not_active IP Right Cessation
- 1991-04-02 AU AU75586/91A patent/AU7558691A/en not_active Abandoned
- 1991-04-02 WO PCT/GB1991/000516 patent/WO1991015197A1/en not_active Ceased
- 1991-04-02 EP EP91907023A patent/EP0524211B2/de not_active Expired - Lifetime
- 1991-04-02 DE DE69108022T patent/DE69108022T3/de not_active Expired - Fee Related
- 1991-04-02 CA CA002079904A patent/CA2079904A1/en not_active Abandoned
- 1991-04-05 PT PT97264A patent/PT97264A/pt not_active Application Discontinuation
- 1991-04-05 NZ NZ237710A patent/NZ237710A/xx unknown
- 1991-04-05 ZA ZA912538A patent/ZA912538B/xx unknown
- 1991-04-05 IE IE114891A patent/IE911148A1/en unknown

Also Published As

Publication number	Publication date
GB9007945D0 (en)	1990-06-06
EP0524211B2 (de)	1999-08-11
JPH05505193A (ja)	1993-08-05
DE69108022T3 (de)	2000-04-20
JP3234946B2 (ja)	2001-12-04
CA2079904A1 (en)	1991-10-08
IE911148A1 (en)	1991-10-09
EP0524211B1 (de)	1995-03-08
ZA912538B (en)	1992-04-29
EP0524211A1 (de)	1993-01-27
NZ237710A (en)	1993-05-26
DE69108022D1 (de)	1995-04-13
PT97264A (pt)	1992-01-31
WO1991015197A1 (en)	1991-10-17
AU7558691A (en)	1991-10-30
DE69108022T2 (de)	1995-07-20

Legal Events

Date	Code	Title	Description
1995-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE119390T1 (de)	1995-03-15	Arzneimittel.
ATE232092T1 (de)	2003-02-15	Ein brause-säure-basepaar enthaltende arzneimittel
NO954240L (no)	1995-10-23	Veterinærpreparat inneholdende en protonpumpeinhibitor
ATE167629T1 (de)	1998-07-15	Arzneimittel mit verzögerter freigabe
DE58900594D1 (de)	1992-01-30	Ibuprofen-brausezubereitungen.
ATE151285T1 (de)	1997-04-15	Orale arzneimittel mit kolonspezifischer freisetzung
SE8902288D0 (sv)	1989-06-22	Farmaceutisk komposition
ATE205090T1 (de)	2001-09-15	Eine glucagon enthaltende pharmazeutische zubereitung
NO910213D0 (no)	1991-01-18	Fremgangsmaate for fremstilling av orale legemiddelformer av pimobendan.
DK0841903T3 (da)	2003-05-19	Orale farmaceutiske præparater indeholdende antimikrobielt virksomme aktivstoffer og sustained release pantoprazol
SE9402431D0 (sv)	1994-07-08	New tablet formulation
DK0673245T3 (da)	1998-04-27	Farmaceutisk brusepræparat indeholdende ibuprofen og fremgangsmåde til dets fremstilling.
ATE83651T1 (de)	1993-01-15	Acetylcystein enthaltende mundloesliche arzneimittel.
ITMI941262A0 (it)	1994-06-17	Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
DE69202696D1 (de)	1995-06-29	Arzneimittel enthaltend Ranitidin/Wismutcarboxylat-Salze.
PH27446A (en)	1993-07-02	Compound with gastric acid inhibitory effect
IS1877B (is)	2003-06-20	Aðferð til framleiðslu á N-metýl-3-(1-metýl-4-píperidinýl)-1H-indól-5- etansúlfonamíð og lífeðlisfræðilega viðunandi söltum þess og lausnum þeirra
CS240991A3 (en)	1992-03-18	Solid forms for oral administration, said forms containing iphosphamide as active component
ATE105474T1 (de)	1994-05-15	Aromatisierte filmbeschichtete tablette.
IL99389A0 (en)	1992-08-18	Amino acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL103743A0 (en)	1993-04-04	Amino acid derivatives,their manufacture and pharmaceutical compositions containing them
GR910300116T1 (en)	1992-03-20	3-l-(5-thioxo-l-prolyl)thiazolidine-4-carboxylic acid and derivatives therefrom, processes for the preparation thereof and pharmaceutical compositions containing them
AU8744691A (en)	1992-06-11	N-((2-thenoylmercapto-3-methyl)-butanoyl)-homocysteine thiolactone, a process for the preparation thereof and pharmaceutical compositions containing it
CA2161683A1 (en)	1994-11-10	Veterinary composition containing a proton pump inhibitor